Search for a trial

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,
PHASE 2A STUDY TO ASSESS THE EFFICACY AND SAFETY OF
REGN3500 MONOTHERAPY AND COMBINATION OF REGN3500 PLUS
DUPILUMAB IN ADULT PATIENTS WITH MODERATE-TO-SEVERE
ATOPIC DERMATITIS

The primary objective of the study is to evaluate the efficacy of REGN3500monotherapy compared with placebo treatment in adult patients withmoderate-to-severe atopic dermatitis (AD).The secondary objectives of the study are:* To evaluate the…